Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
dBET6
i
Other names:
dBET6
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Dana-Farber Cancer Institute
Drug class:
BRD4 degrader
‹
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
KRAS G12D
Pancreatic Ductal Adenocarcinoma
KRAS G12D
Pancreatic Ductal Adenocarcinoma
MRTX1133 + BI 894999 + dBET6
Sensitive: D – Preclinical
MRTX1133 + BI 894999 + dBET6
Sensitive
:
D
MRTX1133 + BI 894999 + dBET6
Sensitive: D – Preclinical
MRTX1133 + BI 894999 + dBET6
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.